Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
37.97
-0.08 (-0.21%)
At close: Aug 28, 2025, 4:00 PM
38.87
+0.90 (2.37%)
After-hours: Aug 28, 2025, 7:38 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $2.18 billion as of August 28, 2025. Its market cap has increased by 15.04% in one year.
Market Cap
2.18B
Enterprise Value
1.79B
1-Year Change
15.04%
Ranking
Category
Stock Price
$37.97
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.18B, an increase of 373.83%. That is a compound annual growth rate of 36.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 2.19B | 11.55% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 655.26B |
| Johnson & Johnson | 425.31B |
| AbbVie | 367.44B |
| UnitedHealth Group | 278.43B |
| Novo Nordisk | 255.49B |
| AstraZeneca | 251.25B |
| Novartis AG | 244.09B |
| Abbott Laboratories | 230.05B |